ee |
2012
| 2011
| 2010
| 2009 | 2008
| 2007
| 2006
| 2005 | 2004 | 2003
| 2002 | 2001 | 2000
| before 2000
2012
(by
reverse chronological order)
- EUCAST breakpoints
13th Congress of the Lebanese Society for Infectious Diseases and Clinical
Microbiology, Beirut, Lebanon, 2-4 February 2012
PDF
- Guidelines in
infectious diseases: from diversity to logics (a study about CAP guidelines)
13th Congress of the Lebanese Society for Infectious Diseases and Clinical
Microbiology, Beirut, Lebanon, 2-4 February 2012
PDF
2011
(by
reverse chronological order)
- Moxifloxacin
safety data review
8th Forschungswerkstatt Moxifloxacin 2011, Leverkusen, Germany, 18 November
2011
PDF
- But where does
the Pharmaceutical Industry go ... and Universities in all that business
?
A3P Symposium Belgium, Spa, Belgium, 16 November 2011
PDF
- Discovery of
new antibiotics: Why and some approaches (with a short presentation
of Belgium and of the Université catholique de Louvain)
International University, Vietnam National University, Ho Chi Minh City,
Vietnam, 10 October 2011
PDF
- Colistin: from
structure to clinical use via microbiology, PK/PD, and toxicology
Bach Mai Hospital, Hanoi, Vietnam (within the context of a cooperative
programme between Wallonie-Bruxelles International and the University
of Pharmacy, Hanoi, Vietnam), 6 October 2011
PDF
- Optimising treatment
based on PK/PD principles
Evolving Antibacterial Therapy - 30 years of clinical experience, 24-25
September, Istanbul, Turkey
PDF
- Towards clinical
Applications of PK-PD in specific situations
51th Interscience Conference onf Antimicrobial Agents and Chemotherapy
(ICAAC), Chicago, IL. - ICAAC/ISAP Workshop - 16 September 2010
PDF
- Guidelines in
lower respiratory tract infections: from diversity to logics
Latin-America consensus meeting on Respiratory Tract Infections ( "Inspiration"
), Rio-de-Janeiro, Brazil, 28-30 July 2011
PDF
- Antibiotic resistance:
are we heading for failures ?
36th Annual Meeting of the International Urogynecological Association,
Lisbon, Portugal, 29 June 2011
Symposium "The guidelines offer more than antibiotics to manage
recurrent urinary tract infections"
PDF
- Towards rational
international antibiotic breakpoints: Actions from the European Committee
on Antimicrobial Susceptibility Testing (EUCAST)
1st International & 12th Iranian Congress of Microbiology, Kermanshah,
Iran, 23-26 May 2011
PDF
- Hunting intracellular
bacteria with antibiotics
1st International & 12th Iranian Congress of Microbiology, Kermanshah,
Iran, 23-26 May 2011
PDF
- Improving
usage by guidelines: a critical view
21st European Congress of Chemotherapy and Infectious Diseases &
27th International Congress of Chemotherapy, Milan, Italy, 7-10 May
2011
Symposium: Bridging the gap of innovation – what we all could do
?
PDF
- Strategies to
combat resistance: Focus on pharmacokinetics/ pharmacodynamics with
applications to beta-lactams and a few words on colistin
- Academy for Infection Management, India -- Mumbai
(12-02) -- Chennai
(13-02) --
Bangalore (14-02) --
Kolkata (15-02) -- Delhi
(16-02) -- calculator
(beta-lactams "concentration vs time" after IV bolus)
(available soon)
- International Critical care Congress
2001(CRITICARE 2001), Delhi 18 February 2011 - PDF
(this set of slides contains also data on vancomycin)
2010
(by
reverse chronological order)
- Respiratory
fluoroquinolones: Benefit-Risk profiles
Belgische Vereniging voor Pneumologie – Société belge
de pneumologie, Antwerp, 27 November 2010
PDF
- Towards clinical
Applications of PK-PD in specific situations
50th Interscience Conference onf Antimicrobial Agents and Chemotherapy
(ICAAC), Boston, Mass. - ICAAC/ISAP Workshop - 11 September 2010
PDF
- Hunting intracellular
bacteria with antibiotics
Invited Lecture - Department of Chemistry and Biochemistry, University
of Notre-Dame, Notre Dame, Indiana, 9 September 2010
PDF
- How do antibiotics
play with multidrug transporters in eucaryotic cells ?
462nd W.E. Heraeus Seminar, Jacobs University, Bremen, Germany, 9 July
2010
PDF
- Antibiotic transporters
in Pseudomonas aeruginosa and Streptococcus pneumoniae:
impact on resistance and clinical significance
(Introductory comment: why do we need but will have difficulties in
getting new antibiotics)
462nd W.E. Heraeus Seminar, Jacobs University, Bremen, Germany, 9 July
2010
PDF
- Antibiotic efflux
in procaryotic and eucaryotic cells: from molecular mechanisms to pharmacological
consequences
Institut National de la Recherche Agronomique, Toulouse, France, 21
May 2010
PDF
- Impact of the
antibiotic treatment on resistance of Pseudomonas aeruginosa
in nosocomial pneumonia, or "Pseudomonas in Brussels in
2010"
Séminaire de microbiologie et maladies infectieuses, Hôpital
Erasme, Université libre de Bruxelles, Brussels, Belgium, 24
March 2010
PDF
- Intracellular
Killing: Where’s the Bug? Where’s the Drug?
Gordon Research Conference "New Antibacterial Discovery & Development",
Galveston, TX, 18 March 2010
PDF
- Update on new
antibiotics in Belgium
Seminar for Clinical pharmacists, Université catholique de Louvain
& Cliniques universitaires St-Luc, Brussels, Belgium, 25 January
2010
PDF
2009
(by
reverse chronological order)
- Aminoglycosides:
What have we learned about toxicity ?
Infectious Diseases Society of America (IDSA) 47th Annual Meeting, Philadelphia,
PA, 29 November 2009
(Symposium # 153: Back to the Future: The Aminoglycosides are Here Again)
PDF
- ABC transporters:
from survival to resistance (or vice-versa)
Colloque ABC franco-belge / ABC French-Belgian Colloquium, Paris, France,
14 October 2009
PDF
- Iron metabolism
and medical needs: a view from Academia
Iron Therapy Master Class, Zürich, Switzerland, 13-15 October 2009
PDF
- Efflux pump
inhibitors to restore antibiotic efficacy
ESCMID/FEMS Conference: "From Microbial Pathogenesis to the Discovery
of Antivirulence Drugs", Les Diablerets, Switzerland, 4-8 October
2009
PDF
- Administration
of beta-lactams by continuous infusion: when, how, and for which molecules
?
49th Interscience Conference on Antimicrobial Agents and Chemotherapy
(ICAAC), San Francisco, CA (Meet-the-Experts – session 202. Optimization
of Beta-Lactams: Continuous and Prolonged Infusions versus Standard
Regimens) - 14 September 2009
PDF
- Updates on treatment
of Staphylococcus aureus / MRSA
26th Annual Meeting of the Scandinavian Society of Antimicrobial Chemotherapy,
Tromsoe, Norway, 5 September 2009
PDF
- Safety of antibiotics
used in respiratory tract infections: benefit-risk profile of moxifloxacin
2009 Annual Meeting of the Finnish Society for Infectious Diseases (satellite
symposium), Helsinki, Finland, 25 August 2009
PDF
- Intracellular
infection and activity of antibiotics: concepts and examples with Staphylococcus
aureus and Listeria monocytogenes
Lecture given at The Turku Center for Immunology, National Public Health
Institute, Turku, Finland, 24 August 2009
PDF
- Antibiotic selection
in community-acquired pneumonia (CAP): appropriate benefit-risk profiles
7th Forschungswerkstatt Moxifloxacin 2011, Leverkusen, Germany, 26 June
2011
PDF
- Collateral effects
of antibiotics: adverse effects and drug interactions
26th International Congress of Chemotherapy and Infection (Meet the
Experts session ME-41), Toronto, Ont., 20th June 2009
PDF
- New antimicrobials
27th Annual meeting of the European Society for Paediatric Infectious
Diseases (ESPID), Brussels, Belgium, 12 June 2009
PDF
- Adopting EUCAST
breakpoints in countries currently on CLSI breakpoints and some personal
thinking…
19th European Congress of Clinical Microbiology and Infectious Diseases
(ECCMID), Helsinki, Finland, 18 May 2009
PDF
- Colistin pharmacokinetics/pharmacodynamics
with an introduction and comments about reasonable uses
19th European Congress of Clinical Microbiology and Infectious Diseases
(ECCMID), Helsinki, Finland, 17 May 2009
PDF
- Antibiotic transporters:
Clinical Implications
Gordon Reserach Conference "Efflux Transporters", Galveston,
TX, 26 March 2009
PDF
- Antibiotics
for Community-acquired pneumonia (CAP): appropriate benefit-risk profiles
- 5th Forum on Respiratory Tract Infections, Sitges (Barcelona), Spain,
5 February 2009 PDF
-
Italian medical educational meeting, Leverkusen, Germany, 6 March 2009
PDF
- 7
Forschungswerkstatt Moxifloxacin, Leverkusen, Germany, 26 June 2009
PDF
- Doripenem vs
meropenem: a summary of international and Belgian published data
Brussels, Belgium, 2 February 2009
PDF
- Deciphering
the activity of antibiotics against intracellular Staphylococcus
aureus with the help of PK/PD (pharmacokinetics/pharmacodynamics)
Seminar held at the Institut für Medizinische Mikrobiologie, Universitätsklinikum
Münster, Germany, 15 January 2009
PDF
2008
(by
reverse chronological order)
- Safety of moxifloxacin
with special reference to the recent labelling change and benefit-risk
ratio
Lecture for Italian Infectious Diseases and Pulmonologists, Leverkusen,
Germany, 2 december 2008
PDF
- New developments
in anti-Gram positive treatments
Société belge d'infectiologie et de microbiologie clinique/Belgische
Vereniging voor Infectiologie en Klnische Microbiologie, La Hulpe, 6
November 2008
PDF
- Pharmacodynamics
of antibiotics in cerebrospinal fluid (CSF): Principles and Consequences
(factors predictive of efficacy)
17ème Conférence de consensus en maladies infectieuses
- Prise en charge des méningites bactériennes aiguës,
Paris, 19 novembre 2008
PDF
(English version - pour une version française: cliquez ici)
- Toxicodynamics
Symposium in honor of Prof. W.A. Craig, University of Madison, School
of Medicine and Public Health, Madison, WI, October 29, 2008
PDF
- How to target
intracellular pathogens
48th Interscience
Conference on Antimicrobial Agents and Chemotherapy (ICAAC) / Infectious
Diseases Society of America(Symposium Pharmacokinetic/Pharmacodynamic
- Factors in Treating Infection in Special Sites and/or Special Pathogens
- session 53), Washington, DC, October 25, 2008
PDF
- Aminoglycoside
nephrotoxicity: a paradigm in toxicodynamic research
48th Interscience Conference on Antimicrobial Agents and Chemotherapy
(ICAAC) / Infectious Diseases Society of America (Symposium Toxicodynamics
- session 72), Washington, DC, October 26, 2008
PDF
- Towards clinical
Applications of PK-PD
48th Interscience Conference on Antimicrobial Agents and Chemotherapy
(ICAAC) / Infectious Diseases Society of America (Workshop), Washington,
DC, October 24, 2008
PDF
- Safety of moxifloxacin
and its benefit-risk ratio in community setting
Educational symposium at the occasion of the 2008 Annual Meeting of
the European Respiratory Society, Berlin, Germany, October 6, 2008
PDF
- From erythromycin
to telithromycin: two bullets for one target ... what makes the difference
?
2nd World Conference on Magic Bullets (Ehrlich II), Nürnberg, Germany,
October 3 - 5, 2008
PDF
- Chemotherapy
and PK/PD of intracellular infections
2nd World Conference on Magic Bullets (Ehrlich II), Nürnberg, Germany,
October 3 - 5, 2008
PDF
- Aminoglycoside
nephrotoxicity: a paradigm in toxicodynamic research
2nd World Conference on Magic Bullets (Ehrlich II), Nürnberg, Germany,
October 3 - 5, 2008
PDF
- Antibiotic transporters:
from Discovery to Clinical Implications
PhD's Day, Académie Bruxelles-Wallonie, Brussels, 20 May 2008
PDF
- Activity of
antibiotics against intracellular S. aureus
European Congress of Clinical Microbiology and Infection (ECCMID), Barcelona,
Spain - 21 April 2008
PDF
2007
(by
reverse chronological order)
- Towards Rational
International Antibiotic Breakpoints: Actions from the European Committee
on Antimicrobial Susceptibility Testing (EUCAST)
Academy of Infection Management, Athens, Greece – 16 November 2007
PDF
- Towards clinical
Applications of PK-PD
47th Interscience Conference on Antimicrobial Agents and Chemotherapy
(Workshops), Chicago, IL, September 16th, 2007
PDF
- Efflux as new
challenge in antibacterial chemotherapy
Transport across membranes: Multiple drug resistance, mechanisms and
new tools. Summer School Jacobs University Bremen, July 8-14th, 2007
PDF
- Inhibitors of
efflux pumps: the long journey from procaryotes to eukaryotes
Transport across membranes: Multiple drug resistance, mechanisms and
new tools. Summer School Jacobs University Bremen, July 8-14th, 2007
PDF
- Molecular bases
for antibiotic resistance through efflux
Transport across membranes: Multiple drug resistance, mechanisms and
new tools. Summer School Jacobs University Bremen, July 8-14th, 2007
PDF
- Towards Rational
International Antibiotic Breakpoints: Actions from the European Committee
on Antimicrobial Susceptibility Testing (EUCAST) and some personal thinking…
Hospital Vesale, Montigny-le-Tilleul, Belgium - May 22d, 2007
PDF
version française
(Le Roeulx [9/11] et Liège [11/11 ])
Nederlandse versie
(Hasselt [4/6], Antwerpen [11/6], Destelgem [18/6])
- Examining the
interaction of drugs and membranes to improve selectivity
Ehancing Screening Strategies with Cell-Based Assays, Informa-Life Sciences
(Informa plc, London, UK), Munich, Germany - February 5-8th, 2007
PDF
- Towards Rational
International Antibiotic Breakpoints: Actions from the European Committee
on Antimicrobial Susceptibility Testing (EUCAST) and some personal thinking…
Seminar for AstraZeneca, Destelbergen, Belgium, January 15, 2007
PDF
- The bad and
good uses of fluoroquinolones in urology
Groupe local d'étude de la médecine (GLEM), Cliniques
universitaires St-Luc, Brussels, Belgium - January 9, 2007
PDF
2006
(by reverse chronological order)
- Are intracellular
drug concentrations relevant for efficacy ? A discussion about accumulation,
efflux and activity …
2006 Joint Fall Meeting of the Nederlandse Vereniging voor Medische
Microbiologie & Vereniging voor Infectie Ziekten, Amsterdam,
The Netherlands, November 16, 2006
PDF
- Towards Rational
International Antibiotic Breakpoints: Actions from the European Committee
on Antimicrobial Susceptibility Testing (EUCAST) and some personal thinking…
"Les midis de l'Infectiologie", Centre hospitalo-universitaire,
Université de Liège, Belgium, November 14, 2006
PDF
- Quinolones,
macrolides, beta-lactams, glycopeptides ... and a few others against
resistant S. aureus
3d International Symposium on Gram-positive Infections, Niagara-on-the
Lake, Ontario, October 9-11th, 2006
PDF
- Pharmacokinetics
of Old and New Glycopeptides
46th Interscience Conference on Antimicrobial Agents and Chemotherapy,
American Society of Microbiology, San Francisco, CA, September 27, 2006
PDF
- Pharmacodynamics
of antibiotics as a means to improve and curb the emergence of resistance
2d International Symposium of the Jordanian Society of Pathology, Amman,
Jordania, August 31, 2006
PDF
- New antistaphylococcal
agents: hopes and limitations
2d International Symposium of the Jordanian Society of Pathology, Amman,
Jordania, August 31, 2006
PDF
- Antibiotic restriction
policies: are they applicable (and desirable) outside the western world ?
2d International Symposium of the Jordanian Society of Pathology, Amman,
Jordania, August 31, 2006
PDF
- Pharmacodynamics
of antibiotics … From what you already knew about " optimizing
activity " ... to what you didn't dare to ask about emergence of
resistance...
Joint Spanish-Belgian Intensive Care meeting, Barcelona, Spain,
April 22, 2006
PDF
- Pharmacodynamics
of antibiotics: Correlation between kinetics and activity
4th Arab Symposium for Antimicrobial Agents / 16th National Tunisian
Congress of Infectiology, Tunis, Tunisia, April 18th, 2006
PDF
- Aminoglycosides:
a new look at old but probably faithfull antibiotics
Research Lecture for Pfizer Central Laboratories, Groton, Conn., April
12, 2006
PDF
- Antibiotic combinations
vs. monotherapy in critical care
AB-Biodisk Educational Workshop, Stockhom, April 5-6, 2003
PDF
- PK/PD modeling
of antibiotics: Clinical Implications
AB-Biodisk Educational Workshop, Stockhom, April 5-6, 2003
PDF
- Pharmacodynamic
indices in targeting therapy of critical infections
AB-Biodisk Educational Workshop, Stockhom, April 5-6, 2003
PDF
- PK/PD of antibiotics:
from theory to applications in the real world...
Joint Italian-Belgian Intensive Care meeting, Milan, Italy, March 18,
2006
PDF
- Use of cell
lines to study specific aspects related to bacterial infections and
antibiotic transport
International Worshop on Cellular Models in Drug Development, London,
UK, February 15, 2006
PDF
- Relationship
between resistance, antibiotic policies, and clinical guidelines in
the community: Government interventions on Antibiotic Policy in Belgium
Libra Initiative European Summit, Brussels, Belgium, January 18, 2006
PDF
2005
- Models of antibiotic
intracellular transport
45th Interscience Conference on Antimicrobial Agents and Chemotherapy,
American Society of Microbiology, Washington, DC, December 19th, 2005
PDF
- How
to choose an antibiotic for respiratory tract infections in 2005
Barcelona, Spain, November 24th, 2005
PDF
- Antibiotic efflux
pumps in eucaryotic cells: consequences for activity against intracellular
bacteria
Journée d'animation scientifique IFR 136 "Agents transmissibles
et infectiologie - Mécanismes d’efflux et résistances
aux agents thérapeutiques", Institut National de la Recherche
Agronomique (INRA), Tours-Nouzilly, France, June 8th, 2005
Web
presentation - PDF
- The pharmacological
and microbiological basis of PK/PD: Why did we have to invent PK/PD
in the first place ?
24th International Congress of Chemotherapy, Manila, Philippines, June
5, 2005
Web
presentation - PDF
- Towards Rational
International Antibiotic Breakpoints: Actions from the European Committee
on Antimicrobial Susceptibility Testing (EUCAST) - A report to the Interntaional
Scociety of Chemotherapy (ICC)
24th International Congress of Chemotherapy, Manila, Philippines, June
4, 2005
PDF
- Azalides revisited:
why the single dose ? The pharmacologist's answer
24th International Congress of Chemotherapy, Manila, Philippines, June
4, 2005
Web
presentation - PDF
2004
- Glycopeptides:
how can a structural modification bring to a new life an old family
of antibiotics ?
Séminaire et Conférences du Département des Sciences
Pharmaceutiques, Université catholique de Louvain, Brussels,
Belgium, December 13th, 2004
Web presentation
- PDF
- Collaborations
on antibiotics with the Rega Institute
Rega Institute 50th Anniversary, Katholieke Universiteit Leuven, Louvain,
Belgium, October 9th, 2004
Web
presentation - PDF
- Belgian
Antibiotic campaigns (2000-2002)
European Workshop on Antibiotic Campaigns, Brussels, Belgium, September
23-24, 2004
Web
presentation - PDF
- Intracellular
antibiotics
World Conference on Magic Bullets - Celebrating Paul Ehrlich's 150th
birthday, Nuremberg, Germany, September 9-11th, 2004
Web presentation
- PDF
- Antibiotic
efflux pumps in eucaryotic cells: consequences for activity against
intracellular bacteria
Cost B16 meeting (European Commission), Ghent, Belgium, May 28th, 2004
Web
presentation - PDF
file
- Setting-up
of a 24 h model to evaluate the activity of antibiotics against intracellular
forms of S. aureus infection
King Pharmaceuticals Workshop, Prague,Czech Republic, May 4th, 2004
Web presentation
- PDF file
- Vancomycin
by continuous infusion ... Why and how ?
GSK-Belgium satellite meeting - 14th European Congress of Chemotherapy,
Prague, Czech Republic, May 3d, 2004
Web
presentation - PDF
file
- MRSA
treatments: does the future shine ?
GSK-Belgium satellite meeting - 14th European Congress of Chemotherapy,
Prague, Czech Republic, May 3d, 2004
Web presentation
- PDF file
- Nephrotoxicity
of Aminoglycosides and Comparisons with Cis-Platinum
American Association for Research in Otolaryngology, Annual Meeting
- Presidential Symposium (Daytona Beach, FL),
February 22, 2004
Web
presentation - PDF
file
2003
- Glycopeptides: from old Mississipi mud to new derivatives
- a critical appraisal
5th European Congress of Chemotherapy, Rhodos, Greece, October 20th,
2003
- Intracellular antibiotics and Listeria monocytogenes
(State of the Art)
5th European Congress of Chemotherapy, Rhodos, Greece, October 19th,
2003
- Efflux Mechanisms of fluoroquinolones and beta-lactams
MSD-closed meeting, September 14th, 2003, Chicago IL
2001
- Intracellular
antibiotic kinetics and dynamics : a reflexion of reality
7th International symposium on New Quinolones, 10-12 June 2001,
Edinburgh, Scotland
- Pharmacokinetics
and Pharmacodynamics in Drug Disvovery, Development and evaluation
Conference given at the Therapeutics and Goods Administration (TGA),
Australian Federal Ministry of Health, Canberra, ACT, Australia, April
9th, 2001
- Pharmacokinetic/
Pharmacodynamics in Antibiotic Evaluation, Clinical use, and Management
of Resistance, ... or PK/PD like magic !
4th Annual Conference of Infectious Diseases Pharmacotherapy, May 3d,
2001, Orlando, Fla.
- What is ISAP ? (a
short description of the International Society of Antiinfective Pharmacology)
4th Annual Conference of Infectious Diseases Pharmacotherapy, May 3d,
2001, Orlando, Fla.
- Pharmacokinetic/
Pharmacodynamics in Drug Discovery, Development and Evaluation.
2d meeting of the Australian
Society of Antimicrobials, Melbourne, Victoria, April 6th, 2001
- Intracellular
Antibiotics : what does it (really) mean ?
2d meeting of the Australian
Society of Antimicrobials, Melbourne, Victoria, April 6th, 2001.
- Pharmacokinetics
and pharmacodynamics for efficacy and prevention of resistance
"Séminaire de Pathologie
Infectieuse", Cliniques universitaires de l'UCL à Mont-Godinne,
Yvoir, March 29th, 2001
- Pharmacokinetics
/ Pharmacodynamics as a mean to improve the medical prescription of
antibiotics
"Séminaire de l'Ecole
de Pharmacie", Université catholique de Louvain, Brussels, Belgium,
March 13, 2001
- Pharmacodynamics as a tool
to improve the antiinfective therapy: from in vitro models to (some)
large-scale clinical applications
Glaxo-SmithKline Belgian
meeting on aminoglycoside monitoring and safety, Brussels, Belgium,
January 17th, 2001
2000
- Isepamicin : discovery
and evaluation of its renal safety
Monthly Infectiology Meeting
of the Flemish-speaking Catholic University of Louvain (Maandelijke
Infectiologie Vergaderingen van de KU-Leuven),
Louvain (Leuven), Belgium, December 20th,
2000
- PK / PD (pharmacokinetics
/ pharmacodynamics) of antibiotics in clinical practice,
Bayer Antiinfective Symposium,
New York, NY, December 8th, 2000
- Pharmacokinetics /
Pharmacodynamics (PK/PD) like magic
Seminars of the Laboratory
of Pharmacology of the University of Geneva (Séminaire du laboratoire de pharmacologie, Université
de Genève), Geneva, Switzerland, December
5th, 2000
- Antibiotic
transporters : biology, medical issues and drug development applications
Belgian Mucoviscidosis
Symposium, Louvain (Leuven), Belgium, November 30th, 2000
- Pharmacokinetics
and Pharmacodynamics of Antibiotics: a key to improved efficacy and
prevention of resistance
- Cox-2 inhibitors:
where are we ?
Belgian Rheumatologists Training Group, Newcastle, UK, November 24th,
2000.
- Aminoglycosides
and beta-lactams: from the work of Paul J. Claes to new recent developments,
"Viering" (Emeritus Ceremony) of Professor P.J. Claes, Flemish-speaking
Catholic University of Louvain (Katholieke Universiteit Leuven),
Louvain (Leuven), Belgium, October 28th, 200) -- The first 5
and the last 2 slides are in Dutch.
- Teicoplanin and
vancomycin: clinical indications and usefullness of drug monitoring,
Seminar of Infectious Pathology (Séminaire
de de pathologie infectieuse), Brussels,
Belgium, October 26th, 2000
- New Goals, New Methods
and New challenges in PK/PD of Antiinfective Agents
7th ISAP International Symposium, Toronto, Ont. September 20th, 2000
- Cell culture methodologies
for assesment of pharmacodynamics and toxicodynamics
Toxicodynamics of New Chemical
entities (Tools for the Safer Design, Selection and Use of New Antibiotics),
40th Interscience Conference on Antimicrobial Agents and Chemotherapy,
Toronto, Ont., September 20th, 2000
- Cellular
and Tissular Accumulation of Drugs: When is it Good and When is
it Bad ?
Antimicrobial resistance:
inevitable or manageable ... ? (Satellite meeting to the 40th Interscience
Conference on Antimicrobial Agents and Chemotherapy, Toronto, Ont.,
September 17th, 2000)
- Dosing appropriately
an antibiotic: does this this really matter ?
Pharmacodynamics: Concepts
and Applications (3d ISAP Educational Workshop), Toronto, Ont., September
16th, 2000
- The concentration-effect
relationships for intracellular micro-organisms (drug trapping, ion
pumps, intracellular MIC)
Resistance and the use
and misuse of antimicrobials, Alton Ochsner Medical Foundation Conferences,
New Orleans, LA, June 26th, 2000
- New
strategies to avoid development of resistance
- Macrolides: pharmacodynamics
and pharmacokinetics.
Macrolides revisited (closed workshop), Brussels, Belgium, June 16-17th,
2000
- Improving antiinfective
therapy: a paradigm of fruitful cooperation between the E.U., Local
Regulatory bodies, Academia and Industry ?
"The cell
factory", an EAG workshop, European Union, Brussels, Belgium, June 11th,
2000
- The
concentration-effect relationships for intracellular micro-organisms
(drug trapping, ion pumps, intracellular MIC)
Education in pharmacokinetics and pharmacodynamics
(2d ISAP Educational Workshop), Stockholm, Sweden, May 28th, 2000
- Intracellular
anti-infectives: is it important for efficacy and do we need to care
for toxicity?
1st Swiss Advisory Board
on the appropriate use of antibiotics (closed meeting), Bern, March
29, 2000
- Isepamicin: an old aminoglycoside
in new clothes ?
Internal training and information
seminar for GlaxoWellcome, Brussels, March 2000
- Pharmacokinetics
/ pharmacodynamics as a step towards a more effective therapy...
3d International Moxifloxacin Symposium, Monte-Carlo, Monaco, February
14th, 2000
- Intracellular
pharmacodynamics: a Journey from Cell biology to the Design of
New Chemotherapeutic Agents
Advances in the Pharmacology of Antiinfective Therapy (1st ISAP
Educational International Symposium), Bangalore, India, January 21st,
2000.
before
2000
- Fluoroquinolones:
structure versus activity and toxicity.
Société Belge
d’Infectiologie et de Microbiologie Clinique/Belgische Vereniging
voor Infectiologie en Klinische Microbiologie, St.-Niklaas, Belgium,
December 11, 1999
- Fluoroquinolones :
from structure to activity,
Internal training and education
seminar for Bristol-Myers/Squibb, Brussels, Belgium, October 25, 1999
- Aminoglycoside
nephrotoxicity: from molecular pharmacology and pathology to some clinical
applications (only part of ythe slides
shown are available),
University of Cincinnati
Medical Center (Division of Nephrology & Hypertension), Cincinnati,
Ohio, October 9, 1999
- Intracellular
infection : a journey from biology to therapy,
University of Cincinnati
Medical Center (College of Pharmacy), Cincinnati, Ohio, October 8, 1999
- In vitro toxicodynamic models to accelerate
drug selection and safety assessment,
9th Symposium of the International Society for Anti-infective Pharmacology,
Birmingham, United Kingdom, July 3, 1999
- Antibiotic use : is it
time for a change ? My personal view,
Joint EMEA (European Agency
for the Evaluation of Medicinal Products) / ISAP (International Society
of Antiinfective Pharmacology), Uppsala, Sweden, June 10, 1999
- Can computer modelling predict the
intracellular activity of antibiotics,
Symposium “Computer
modelling of antibiotic response”, 9th European Congress of Clinical
Microbiology and Infectious Diseases (ECCMID), Berlin, Germany, March
24, 1999
- Intracellular anti-infectives:
is it important for efficacy and do we need to care for toxicity?
1st workshop of the International
Society of Antiinfective Pharmacology, Berlin, Germany, March 21,1999
- Pharmacokinetics and Pharmacodynamics
in action : a view from the patient,
1st workshop of the International
Society of Antiinfective Pharmacology, Berlin, Germany, March 21,1999
- Pharmacokinetic/ Pharmacodynamics
in Drug Development and Evaluation
FDA / ISAP Workshop “Pharmacodynamics
and the impact on antiinfective drug development”, Rockville,
MD, March 1, 1999
(Presidential address on behalf of the International Society of Antiinfective
Pharmacology)
- Problems arising from
the use of modern antibiotics
Opening lecture at the Annual Meeting of the Portuguese Society for
Microbiology and Infectious Diseases, Coimbra, Portugal, February 25,
1999
- Antibiotic uptake
in cells: do liposomes help ?
Symposium “"Pharmacological issues for antimicrobial Therapy
using liposomes"
38th Interscience Conference on Antimicrobial Agents and Chemotherapy,
American Society of Microbiology, San Diego, CA, September 25, 1998
- Cultured cells models for the prospective
assessment of anti-infective toxicity
Pharmacodynamics of Antiinfective
Drugs as a Way to accelerate Drug Pre-clinical and Clinical Development,
International Society of Antiinfective Pharmacology, San Diego, CA,
September 23, 1998
- Defining the requirements
for an intracellular antibiotic,
Pharmacodynamics of Antiinfective
Drugs as a Way to accelerate Drug Pre-clinical and Clinical Development,
International Society of Antiinfective Pharmacology, San Diego, CA,
September 23, 1998
- Antibiotic distribution and activity
in cells,
Chlamydia pneumoniae Consensus
Conference, Carefree, AZ, June 13, 1998
- Can
we define breakpoints for intracellular infections ?
Pharmacokinetic/pharmacodynamic Interactions : concepts, controversies
and challenges, International Society of Antiinfective Pharmacology/Paul
Ehrlich Gesellschaft/2d European Congress of Chemotherapy, Hamburg,
Germany, May 10, 1998
|
Conférences
en français - 
Voordrachten
in het Nederlands